The Smart Investor
    Facebook Instagram
    Thursday, July 16
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»Beyond the Blue-Chips: 3 Rising Stars That Could Enter the STI
    Dividend Stocks

    Beyond the Blue-Chips: 3 Rising Stars That Could Enter the STI

    3 Singapore companies are emerging as strong STI contenders with growth, scale and resilient earnings.
    Zheng Long T.By Zheng Long T.November 11, 2025Updated:November 13, 20256 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    iFAST Singapore
    Image credit: ifastcorp.com
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    The iEdge Singapore Next 50 Index tracks companies that sit just outside the Straits Times Index (SGX:^STI), often seen as the “next in line” to join the ranks of Singapore’s top 30 blue-chips.

    These rising stars combine growing market caps, resilient earnings, and expanding institutional interest.

    We spotlight three companies positioned for potential STI inclusion: iFAST Corporation Limited (SGX: AIY), Parkway Life REIT (SGX: C2PU), Sheng Siong Group Limited (SGX: OV8).

    Why the STI matters

    When a company joins the STI, it’s like getting promoted to the premier league.

    STI membership brings heightened visibility and institutional investment, which typically leads to improved trading liquidity and share price revaluation. 

    But companies don’t get into the STI by luck. 

    They need solid fundamentals, consistent earnings, and the scale to compete with Singapore’s biggest names –  that screening process alone tells you something about their quality.

    iFAST Corporation Limited (SGX: AIY)

    iFAST Corporation Limited (iFAST) operates a wealth management platform, providing a comprehensive range of investment products and services to financial advisory firms, financial institutions, banks, and sophisticated investors in Asia.

    In iFAST’s latest 3Q2025 result, the group’s net revenue saw a jump of 39.9% year on year (YoY) to S$89.5 million and its net profit grew by 54.7% YoY to S$26 million.

    This was supported by growth in the Hong Kong ePension business, a turnaround of iFAST Global Bank as well as sustained momentum in the group’s core wealth management platform business. 

    At the same time, Return on Equity (ROE) stood healthy at 26.1% for the first nine months of 2025. 

    iFAST’s board of directors expects to propose a total dividend per share of S$0.082 for 2025 or higher, representing an increase of at least 39% YoY.

    One key growth driver ahead for iFAST will be to expand its presence in key markets such as Malaysia and China, and new opportunities in the Middle East and Europe. 

    This expansion will help support iFAST’s revenue diversification and grow its pool of customer base.

    Meanwhile, iFAST is in the midst of developing a digital bank, to provide seamless banking services to its wealth management clients. 

    With the digital bank, iFAST can offer an integrated and comprehensive suite of financial services and stands to attract more potential customers.

    iFAST’s sector leadership, strong earnings growth profile, combined with multiple levers of growth and revenue diversification across different geographies, make it a strong contender for the STI.

    ParkwayLife REIT (SGX: C2PU)

    ParkwayLife REIT (PLife REIT) is one of Asia’s largest listed healthcare REITs, with a diversified portfolio of healthcare and healthcare-related assets across Asia-Pacific and Europe.

    Global ageing demographics and rising healthcare spending continue to benefit PLife REIT’s healthcare and nursing properties.

    In addition, the REIT has established a strong brand name in the healthcare property sector, known for its high-quality properties and reliable management, thereby attracting premium tenants and investors.

    For the first nine months of 2025 (9M2025), gross revenue rose 8.2% YoY to S$117.3 million and net property income grew by 8.1% YoY to S$110.7 million.

    Distributable income to unitholders increased by 10.4% YoY to S$75.4 million – the improved overall performance was largely attributed to the acquisition of 11 nursing homes in France and one nursing home in Japan.

    On the capital management front, the REIT remained prudent with a gearing ratio of just 35.8% and interest coverage ratio stood at a robust level of 8.9 times.

    To mitigate interest rate risk, management has locked in rates for 97% of its debt exposure.

    Meanwhile, continued focus on asset enhancement initiatives and built-in rental escalation in lease agreements allow existing properties to increase in valuation and ensure steady growth in revenue over time.

    PLife REIT’s long track record of growth in its financial performance, exposure to favorable demographic trends, and experienced management could propel the REIT into the STI.

    Sheng Siong Group Limited (SGX: OV8)

    Sheng Siong Group Limited (Sheng Siong) operates a chain of supermarkets primarily in Singapore. 

    The company focuses on providing a mix of both live and fresh produce, frozen and processed foods, essential household merchandise, as well as other general merchandise.

    In Sheng Siong’s latest 3Q2025 results, the group recorded revenue of S$415.5 million and net profit S$43.8 million, up 14.4% and 12% YoY, respectively. 

    The growth was mainly driven by the establishment of 11 new stores compared to a year ago, along with improvement in the sales mix as well.

    The supermarket operator’s recent announcement on the construction of a warehouse, distribution centre and headquarters at the Sungei Kadut property is a key growth driver for the supermarket chain.

    This latest investment will help support the growth plan of Sheng Siong, which has a target of adding three stores each year across the next 10 to 15 years. 

    Within the Sungei Kadut property, the company plans to leverage on advanced systems such as automated storage and retrieval systems (“ASRS”), robotics, and smart inventory management, improving cost efficiency and flexibility to support its expansion plan in the long term.

    With Sheng Siong’s long operational track record, sizable market share and market leadership in Singapore, plus a well-laid expansion plan and growth potential ahead, the group is well-positioned for STI inclusion.

    What this means for investors

    These companies mentioned may not have joined the big leagues of the STI yet, but their growth trajectories and strong fundamentals suggest significant potential.

    Investors looking beyond blue chips can capture both capital appreciation and dividend income.

    Early entry into these rising stars offers exposure before institutional buying drives valuations higher.

    Get Smart: Tomorrow’s Blue Chips Are Today’s Challengers

    Today’s STI heavyweights were once yesterday’s challengers knocking on the door.

    Companies like iFAST Corporation Limited, Parkway Life REIT and Sheng Siong Group Limited demonstrate that tomorrow’s index heavyweights are already building their track records today.

    Long-term investors know the real opportunity: the next STI winners aren’t in the index yet – they’re just outside it, waiting to be discovered.

    If you want to retire with a constant stream of dividends, these 5 stocks might be all you need. We’ve found 5 SG stocks that have kept paying (and growing) through inflation, rate hikes, and recessions. See what they are with our latest free report for SGX dividend investors. Click here to get instant access.

    Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses!

    Disclosure: Zheng Long does not own any shares of the companies mentioned.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Sembcorp Industries

    Top 6 Temasek-Backed SGX Blue-Chip Stocks

    July 16, 2026
    Vicom (Pic by Felicia)

    Hidden Gems: 3 Debt-Free Stocks for Paying More than Your CPF

    July 16, 2026
    Singtel vs Starhub

    Singtel vs StarHub: Examining Free Cash Flow Payout Ratios for Income Investors

    July 16, 2026
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.